By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xenon Pharmaceuticals Inc. (Formerly Xenon Genetics) 

3650 Gilmore Way

Burnaby  British Columbia  V5G 4W8  Canada
Phone: 604-484-3300 Fax: 604-484-3450


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
Xenon Pharma Reports Second Quarter 2017 Financial Results and Provides Corporate Update 8/4/2017 11:48:56 AM
Xenon Pharma To Host Conference Call And Webcast Today At 9:00 A.M. Eastern Time To Discuss Topline Results From TV-45070 Phase IIb Clinical Trial In PHN 6/27/2017 8:13:02 AM
Teva (TEVA), Xenon Pharma's Nerve Pain Med Fails To Meet All Endpoints In Phase III Study 6/27/2017 7:18:35 AM
Teva (TEVA) And Xenon Pharma Announce Phase II Study Of Topical TV-45070 In Patients With Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint 6/27/2017 6:32:34 AM
Xenon Pharma Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/10/2017 11:08:05 AM
Xenon Pharma To Host Conference Call And Webcast To Discuss First Quarter 2017 Financial Results And Provide Corporate Update 5/5/2017 11:31:04 AM
Xenon Pharma Expands Ion Channel Neurology Pipeline With Acquisition Of New Potassium Channel Modulator For The Treatment Of Epilepsy 4/26/2017 5:59:32 AM
Xenon Pharmaceuticals Inc. Dumps Acne Drug After Trial Failure 3/24/2017 8:32:59 AM
Xenon Pharmaceuticals Inc. Reports 2015 Financial Results And Provides Corporate Update 3/9/2016 8:10:07 AM
Xenon Pharmaceuticals Inc. To Present At The Stifel 2015 Healthcare Conference 11/13/2015 10:08:24 AM
123456
//-->